Lisa Paborsky
Director de Operaciones en Ilios Therapeutics, Inc. .
Perfil
Lisa Paborsky is currently holding two positions as SVP-Corporate Development & Strategic Relations at Mitobridge, Inc. and as Chief Operations Officer at Ilios Therapeutics, Inc. She holds a doctorate degree from Stanford University and an undergraduate degree from State University of New York at Binghamton.
Cargos activos de Lisa Paborsky
| Empresas | Cargo | Inicio |
|---|---|---|
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ilios Therapeutics, Inc.
 Ilios Therapeutics, Inc. Packaged SoftwareTechnology Services Ilios Therapeutics, Inc. develops a chemistry platform to generate therapeutics for neurodegenerative diseases. The American company was founded by Luca Giani and he has been the CEO since incorporation. | Director de Operaciones | - |
Formación de Lisa Paborsky.
| Stanford University | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Health Technology |
Ilios Therapeutics, Inc.
Ilios Therapeutics, Inc. Packaged SoftwareTechnology Services Ilios Therapeutics, Inc. develops a chemistry platform to generate therapeutics for neurodegenerative diseases. The American company was founded by Luca Giani and he has been the CEO since incorporation. | Technology Services |
- Bolsa de valores
- Insiders
- Lisa Paborsky
